Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-3002 in Children With Idiopathic Short Stature
NCT01786902Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- Feb 2012
- Primary completion
- Apr 2014
01
Overview
A Phase 3 trial of Growtropin-II in Idiopathic Short Stature (ISS), sponsored by Dong-A ST. Started Feb 2012; status: completed.
02
Drugs
Growtropin-II
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT01786902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786902.